These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 10713627

  • 1. Allogeneic peripheral blood hematopoietic stem cell transplantation: guidelines for red blood cell immuno-hematological assessment and transfusion practice.Société Française de Greffe de Moelle.
    Lapierre V, Kuentz M, Tiberghien P.
    Bone Marrow Transplant; 2000 Mar; 25(5):507-12. PubMed ID: 10713627
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multiple red cell alloantibodies, including anti-Dib, after allogeneic ABO-matched peripheral blood progenitor cell transplantation.
    Zupańska B, Zaucha JM, Michalewska B, Malinowska A, Brojer E, Hellmann A.
    Transfusion; 2005 Jan; 45(1):16-20. PubMed ID: 15647013
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 7. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
    Scholl S, Klink A, Mügge LO, Schilling K, Höffken K, Sayer HG.
    Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation.
    Yazer MH, Triulzi DJ.
    Curr Opin Hematol; 2007 Nov; 14(6):664-70. PubMed ID: 17898572
    [Abstract] [Full Text] [Related]

  • 12. Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.
    Ozkurt ZN, Yegin ZA, Yenicesu I, Aki SZ, Yagci M, Sucak GT.
    Transplant Proc; 2009 Nov; 41(9):3851-8. PubMed ID: 19917400
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
    Michallet M, Le QH, Mohty M, Prébet T, Nicolini F, Boiron JM, Esperou H, Attal M, Milpied N, Lioure B, Bordigoni P, Yakoub-Agha I, Bourhis JH, Rio B, Deconinck E, Renaud M, Chir Z, Blaise D.
    Exp Hematol; 2008 May; 36(5):535-44. PubMed ID: 18346838
    [Abstract] [Full Text] [Related]

  • 16. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].
    Michallet M, Dhedin N, Michallet AS.
    Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365
    [Abstract] [Full Text] [Related]

  • 17. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
    Mueller RJ, Stussi G, Odermatt B, Halter J, Schanz U, Seebach JD.
    Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.